Archive - March 2022
WHO: High-Risk COVID-19 Patients Should Take This Drug
COVID: How Anti-Vaccine Influencers Exploit Mothers
Quotable Pharma: A year in review
NICE recommends Amgen’s Lumykras for non-small-cell lung cancer
FDA issues final guidances for clinical cancer trials
First RSV vaccine trial for infants offers significant results
Previously untreatable lung cancer patients offered new therapy
More Free At-Home COVID Tests Are Available To Americans: Here’s How To Get Them